Solmeron, Adelai9da D.

HRN: 25-01-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/23/2024
04/30/2024
IV
600mg
Q8hrs
Infected Wound
Waiting Final Action 
04/23/2024
CEFTAZIDIME 1GM (VIAL)
04/23/2024
04/30/2024
IV
1gm
TID
Infected Wound
Waiting Final Action 
04/26/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/26/2024
05/03/2024
IVT
4.5g
Q8
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: